Immediate Impact
2 standout
Citing Papers
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
2025 Standout
Works of Kara Higgins being referenced
First results of a head-to-head trial of acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia.
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Kara Higgins | 93 | 83 | 4 | 30 | 7 | 107 | |
| Rebecca Frewin | 119 | 95 | 6 | 55 | 12 | 176 | |
| Christina Howlett | 68 | 140 | 1 | 93 | 11 | 166 | |
| Anouk de Jong | 96 | 64 | 7 | 17 | 7 | 111 | |
| Betty Prine | 50 | 40 | 31 | 6 | 109 | ||
| Sabrina Leonetti Crescenzi | 167 | 146 | 7 | 15 | 6 | 175 | |
| Yufu Lin | 49 | 34 | 3 | 20 | 7 | 76 | |
| G. Barosi | 47 | 35 | 23 | 10 | 97 | ||
| Joan E. Ramis-Zaldivar | 81 | 155 | 2 | 107 | 6 | 172 | |
| Martyn Ronald Schaafsma | 69 | 50 | 4 | 54 | 11 | 171 | |
| Norbert Grobe | 22 | 51 | 1 | 43 | 9 | 104 |
All Works
Loading papers...